ACM
IDXX icon

Aster Capital Management’s Idexx Laboratories IDXX Stock Holding History

Aster Capital Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$569K Buy
1,080
+1,004
+1,321% +$563K 0.12% 243
2026
Q1 		$31.9K Sell
76
-18
-19% -$11.5K 0.01% 500
2025
Q4 		$63.6K Sell
94
-101
-52% -$68.8K 0.03% 424
2025
Q3 		$125K Sell
195
-3,735
-95% -$2.27M 0.06% 343
2025
Q2 		$2.11M Buy
3,930
+3,699
+1,601% +$1.77M 0.48% 49
2025
Q1 		$101K Buy
+231
New +$100K 0.02% 651

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Aster Capital Management's IDXX Position: Q2 2026 in Review

Aster Capital Management increased its Idexx Laboratories (IDXX) stake by 1,321% in Q2 2026, buying an estimated $563K and bringing the position to 1,080 shares worth $569K. The position accounts for 0.12% of the portfolio, ranked #243.

Aster Capital Management first reported a position in IDXX in Q1 2025 and has held it in 6 quarters since. The position peaked at $2.11M in Q2 2025. 1,305 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Aster Capital Management held 1,080 shares of Idexx Laboratories worth $569K as of Q2 2026.
  • Aster Capital Management bought 1,004 Idexx Laboratories shares in Q2 2026, an estimated $563K.
  • Idexx Laboratories made up 0.12% of Aster Capital Management's portfolio in Q2 2026, its #243 holding.
  • Aster Capital Management first reported a position in Idexx Laboratories in Q1 2025 and has held it in 6 quarters since.
  • Aster Capital Management's Idexx Laboratories position peaked at $2.11M in Q2 2025.
  • 1,305 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Aster Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.